Physician profile
Deborah Murray
NPI 1376047480
$3,285.57
in general payments reported to CMS, 2019-2025
32 companies · $25.55 in 2025
The $25.55 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $900 · 2022: $1,811 · 2023: $512 · 2024: $36.41 · 2025: $25.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventric Diagnostics, INC. | $394.99 | 2022 | |
| Sanofi-Aventis U.S. LLC | $371.84 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $307.84 | 2021-2023 | Farxiga |
| Abbott Laboratories | $269.04 | 2022-2023 | Freestyle Libre 3 |
| Novo Nordisk INC | $251.09 | 2021-2023 | Tresiba, Ozempic, Rybelsus |
| Mannkind Corporation | $201.48 | 2021-2023 | Afrezza |
| Corcept Therapeutics | $167.20 | 2021-2022 | |
| Lilly USA, LLC | $153.01 | 2021-2023 | |
| Dexcom, INC. | $124.18 | 2021-2023 | Dexcom G6 Transmitter |
| Abbvie INC. | $118.35 | 2021-2024 | |
| Insulet Corporation | $113.79 | 2021-2023 | Omnipod |
| Nestle Healthcare Nutrition INC. | $98.93 | 2022 | |
| Allergan, INC. | $88.09 | 2021 | |
| Hollister Incorporated | $87.79 | 2023 | Premier, Adapt Ceraring |
| Bayer Healthcare Pharmaceuticals INC. | $73.27 | 2022-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amryt Pharma Holdings LTD | $54.46 | 2022 | |
| Amarin Pharma, INC. | $53.06 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.98 | 2021-2022 | |
| Ibsa Pharma INC. | $33.96 | 2021 | |
| Roche Diabetes Care, INC. | $30.47 | 2022 | |
| Boston Scientific Corporation | $29.23 | 2022 | |
| Intuity Medical INC | $28.19 | 2022 | |
| Medtronic, INC. | $25.91 | 2022 | |
| Tactile Systems Technology INC | $25.55 | 2025 | Flexitouch Plus, Nimbl |
| Genentech USA, INC. | $23.02 | 2021 | |
| Cmp Pharma, INC. | $20.78 | 2021 | |
| Amgen INC. | $18.51 | 2022 | |
| Paratek Pharmaceuticals, INC. | $17.73 | 2021 | |
| Radius Health, INC. | $17.27 | 2021 | |
| Clarus Therapeutics INC. | $14.11 | 2021 | |
| Evoke Pharma, INC. | $11.31 | 2021 | |
| Xeris Pharmaceuticals, INC. | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.